Vuf-5296

Vuf-5296

SCHEMBL6136537

NC1CC1c1c[nH]cn1

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Vuf-5296 SCHEMBL7784076 1.00
Vuf-5297 SCHEMBL7508989 1.00
Vuf-5296 SCHEMBL8846403 1.00
Vuf-5296 SCHEMBL8846552 1.00
SCHEMBL2895063 0.80
SCHEMBL6136828 0.76 HRH3 (0.46)
SCHEMBL2262101 0.76 HRH3 (0.46)
SCHEMBL8846230 0.75
SCHEMBL8846549 0.75
Hydrochloric Acid SCHEMBL6782159 0.75 HRH3 (0.45)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0841923-B1 1H-4(5)-SUBSTITUTED IMIDAZOLE DERIVATIVES GLIATECH INC (US) 2002-09-18 EP claimed
EP-0214058-B1 PHARMACEUTICAL COMPOSITION CONTAINING HISTAMINE DERIVATIVES INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) (FR) 1992-05-06 EP claimed
EP-1313470-A4 NOVEL ALICYCLIC IMIDAZOLES AS H 3 AGENTS GLIATECH INC (US) 2005-02-16 EP disclosed
US-6794405-B2 Alicyclic imidazoles as H3 agents MERCK & CO., INC. 2004-09-21 US disclosed
US-20040029943-A1 Novel alicylic imidazoles as H3 agents MERCK SHARP & DOHME CORP. 2004-02-12 US disclosed
EP-1313470-A1 NOVEL ALICYCLIC IMIDAZOLES AS H 3 AGENTS GLIATECH, INC. (US) 2003-05-28 EP disclosed
EP-0655914-B1 Use of Histamine-2 agonists for treatment of sexual dysfunction NAHOUM CESAR ROBERTO DIAS (BR) 2003-02-26 EP disclosed
US-20020042400-A1 Novel alicyclic imidazoles as H3 agents GLIATECH, INC. 2002-04-11 US disclosed
WO-2002013821-A1 NOVEL ALICYCLIC IMIDAZOLES AS H3 AGENTS GLIATECH, INC. (US) 2002-02-21 WO disclosed
US-20010047100-A1 Chiral imidazoyl intermediates for the synthesis of 2-(4-imidazoyl)-cyclopropyl derivatives KJAERSGAARD HANS JOERGEN (DK) 2001-11-29 US disclosed
WO-2001081317-A1 CHIRAL IMIDAZOYL INTERMEDIATES FOR THE SYNTHESIS OF 2-(4-IMIDAZOYL)-CYCLOPROPYL DERIVATIVES GLIATECH, INC. (US) 2001-11-01 WO disclosed
US-5908853-A THERAPY FOR SEXUAL DISORDERS Nahoum, Cesar Roberto Dias (BR) 1999-06-01 US disclosed
EP-0655914-A4 NOVEL COMPOSITIONS. NAHOUM CESAR ROBERTO DIAS (BR) 1998-04-22 EP disclosed
EP-0482183-B1 HISTAMINE H3-RECEPTOR AGONIST COMPOUNDS FOR THERAPEUTIC USE, PHARMACEUTICAL COMPOSITIONS ACTING AS AGONISTS OF SAID RECEPTOR AND METHOD OF PREPARATION INST NAT SANTE RECH MED (FR) 1997-07-30 EP disclosed
US-5652258-A HISTAMINE ANTAGONISTS GLIATECH, INC. (US) 1997-07-29 US disclosed
EP-0655914-A1 NOVEL COMPOSITIONS NAHOUM, Cesar Roberto Dias (BR) 1995-06-07 EP disclosed
US-5342960-A Azomethines agonist compounds of the histamine H3 receptor for therapeutic use, pharmaceutical compositions acting as agonists of the said receptor and preparation process INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (FR) 1994-08-30 US disclosed
WO-1994004120-A2 METHODS OF TREATING SEXUAL DYSFUNCTION IN ANIMALS WITH AND H AGONIST NAHOUM CESAR ROBERTO DIAS (BR) 1994-03-03 WO disclosed
WO-1991017146-A1 NOVEL HISTAMINE H3-RECEPTOR AGONIST COMPOUNDS FOR THERAPEUTIC USE, PHARMACEUTICAL COMPOSITIONS ACTING AS AGONISTS OF SAID RECEPTOR AND METHOD OF PREPARATION INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (FR) 1991-11-14 WO disclosed
US-4767778-A HISTAMINE DERIVATIVES INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) (FR) 1988-08-30 US disclosed